Insider Stock Trading History of Mcglynn Margaret G


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Mcglynn Margaret G since year 2005. The trader's CIK number is 1215126. At the time of this reporting, Mcglynn Margaret G is the Director of Vertex Pharmaceuticals Inc / Ma . (stock ticker symbol VRTX). See this page for all insider trading activities at Vertex Pharmaceuticals Inc / Ma .

Note that in the past MCGLYNN MARGARET G also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Mcglynn Margaret G since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-11-18 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 12,500 57.27 715,875
2015-11-18 VRTX Vertex Pharmaceuticals Inc / Ma Sale 12,500 130.15 1,626,875
2015-11-10 FOLD Amicus Therapeutics Inc Buy 10,000 10.27 102,660
2015-08-03 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 12,500 57.27 715,875
2015-08-03 VRTX Vertex Pharmaceuticals Inc / Ma Sale 12,500 137.74 1,721,725
2015-06-01 VRTX Vertex Pharmaceuticals Inc / Ma Sale 12,500 127.16 1,589,437
2015-06-01 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 12,500 55.56 694,500
2015-04-06 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 12,500 53.85 673,125
2015-04-06 VRTX Vertex Pharmaceuticals Inc / Ma Sale 12,500 118.55 1,481,900
2012-11-07 VRTX Vertex Pharmaceuticals Inc / Ma Buy 1,000 45.50 45,500
2009-03-03 MRK Merck & Co Inc Option Ex 29,387 .00 0
2008-02-25 MRK Merck & Co Inc Option Ex 30,541 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcglynn Margaret G (Director of Vertex Pharmaceuticals Inc / Ma at the time of this reporting) see the Securities and Exchange Commission (SEC) website.